Stopping Renin-Angiotensin System Inhibitors in Patients with Advanced CKD and Risk of Adverse Outcomes: A Nationwide Study.

MLA

Fu, Edouard L., et al. “Stopping Renin-Angiotensin System Inhibitors in Patients with Advanced CKD and Risk of Adverse Outcomes: A Nationwide Study.” Journal of the American Society of Nephrology : JASN, vol. 32, no. 2, Feb. 2021, pp. 424–35. EBSCOhost, https://doi.org/10.1681/ASN.2020050682.

APA

Fu, E. L., Evans, M., Clase, C. M., Tomlinson, L. A., van Diepen, M., Dekker, F. W., & Carrero, J. J. (2021). Stopping Renin-Angiotensin System Inhibitors in Patients with Advanced CKD and Risk of Adverse Outcomes: A Nationwide Study. Journal of the American Society of Nephrology : JASN, 32(2), 424–435. https://doi.org/10.1681/ASN.2020050682

Chicago

Fu, Edouard L, Marie Evans, Catherine M Clase, Laurie A Tomlinson, Merel van Diepen, Friedo W Dekker, and Juan J Carrero. 2021. “Stopping Renin-Angiotensin System Inhibitors in Patients with Advanced CKD and Risk of Adverse Outcomes: A Nationwide Study.” Journal of the American Society of Nephrology : JASN 32 (2): 424–35. doi:10.1681/ASN.2020050682.